Insider Trading Arrangements |
3 Months Ended |
---|---|
Jun. 30, 2025
shares
| |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | On April 23, 2025, Dr. Cynthia Friend, a member of the Company’s Board of Directors, terminated a trading plan she had previously adopted with respect to the sale of securities of the Company’s common stock, intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act (“Rule 10b5-1 Trading Plan”). Dr. Friend’s Rule 10b5-1 Trading Plan was adopted on February 18, 2025, and provided for the sale of up to (a) 5,192 shares of the Company’s Common Stock underlying time-based restricted stock units and (b) 4,300 shares of Common Stock underlying stock options granted under an equity compensation plan. As of the date of termination of her Rule 10b5-1 Trading Plan, Dr. Friend did not sell any shares of common stock under the terms of the Rule 10b5-1 Trading Plan. |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Dr Cynthia Friend [Member] | |
Trading Arrangements, by Individual | |
Name | Dr. Cynthia Friend |
Title | Board of Directors |
Rule 10b5-1 Arrangement Terminated | true |
Termination Date | April 23, 2025 |
Dr Cynthia Friend Trading Arrangement Common Stock Underlying Time Based Restricted Stock Units [Member] | Dr Cynthia Friend [Member] | |
Trading Arrangements, by Individual | |
Aggregate Available | 5,192 |
Dr Cynthia Friend Trading Arrangement Common Stock Underlying Employee Stock Options [Member] | Dr Cynthia Friend [Member] | |
Trading Arrangements, by Individual | |
Aggregate Available | 4,300 |